Literature DB >> 28498508

Stroke in Women: Risk Factors and Clinical Biomarkers.

Hamed Mirzaei1.   

Abstract

Stroke has been emerged as one of major health problems for women worldwide. Increasing of knowledge in this field has provided new data in this area which contribute to finding of new risk factors and could improve stroke treatment. A large number studies indicated a variety of risk factors including sex, age, race, smoking, diabetes, and physical inactivity could be involved in stroke in women. The understanding of various aspects involved in women stroke including risk factors, outcomes, stroke recovery, and prevention could provide new therapeutic platforms which could likely lead to better treatment in women stroke. Diagnosis is one of important steps in stroke therapy. It has been showed that a variety of biomarkers such as microRNAs (miRNAs), tPA, and von willebrand factor could be used as therapeutic and diagnostic biomarkers in stroke therapy. Here, we summarized various aspects of stroke in women which could help to recognition risk factors, outcomes, care, treatment, and novel biomarkers involve in treatment of stroke. J. Cell. Biochem. 118: 4191-4202, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  BIOMARKER; RISK FACTOR; STROKE; WOMEN

Mesh:

Substances:

Year:  2017        PMID: 28498508     DOI: 10.1002/jcb.26130

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  17 in total

Review 1.  The Story of Nanoparticles in Differentiation of Stem Cells into Neural Cells.

Authors:  Vajihe Asgari; Amir Landarani-Isfahani; Hossein Salehi; Noushin Amirpour; Batool Hashemibeni; Saghar Rezaei; Hamid Bahramian
Journal:  Neurochem Res       Date:  2019-11-12       Impact factor: 3.996

2.  Association of MicroRNAs With Risk of Stroke: A Meta-Analysis.

Authors:  Yidong Deng; Peijian Huang; Fan Zhang; Tao Chen
Journal:  Front Neurol       Date:  2022-05-19       Impact factor: 4.086

3.  FOXA1-induced circOSBPL10 potentiates cervical cancer cell proliferation and migration through miR-1179/UBE2Q1 axis.

Authors:  Shanshan Yang; Yiwen Jiang; Xiaoli Ren; Dan Feng; Liaoyun Zhang; Deying He; Shiyao Hong; Li Jin; Fang Zhang; Shun Lu
Journal:  Cancer Cell Int       Date:  2020-08-12       Impact factor: 5.722

4.  Estrogen and progesterone attenuate glutamate neurotoxicity via regulation of EAAT3 and GLT-1 in a rat model of ischemic stroke.

Authors:  Sara Nematipour; Zeinab Vahidinia; Majid Nejati; Homayon Naderian; Cordian Beyer; Abolfazl Azami Tameh
Journal:  Iran J Basic Med Sci       Date:  2020-10       Impact factor: 2.699

Review 5.  Clinical perspectives on ischemic stroke.

Authors:  Atsushi Mizuma; Midori A Yenari
Journal:  Exp Neurol       Date:  2021-01-10       Impact factor: 5.330

Review 6.  Cardiac complications in inherited mitochondrial diseases.

Authors:  Mohaddeseh Behjati; Mohammad Reza Sabri; Masood Etemadi Far; Majid Nejati
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.214

7.  Direct Conjugation of Retinoic Acid with Gold Nanoparticles to Improve Neural Differentiation of Human Adipose Stem Cells.

Authors:  Vajihe Asgari; Amir Landarani-Isfahani; Hossein Salehi; Noushin Amirpour; Batool Hashemibeni; Mohammad Kazemi; Hamid Bahramian
Journal:  J Mol Neurosci       Date:  2020-06-08       Impact factor: 3.444

Review 8.  Chronic obstructive pulmonary disease: MicroRNAs and exosomes as new diagnostic and therapeutic biomarkers.

Authors:  Jafar Salimian; Hamed Mirzaei; Abdullah Moridikia; Asghar Beigi Harchegani; Amirhossein Sahebkar; Hossein Salehi
Journal:  J Res Med Sci       Date:  2018-03-27       Impact factor: 1.852

9.  Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease.

Authors:  Yanyan Zhao; Ao Shen; Feng Guo; Yi Song; Na Jing; Xiaoxu Ding; Mengxing Pan; Haohao Zhang; Jiao Wang; Lina Wu; Xiaojun Ma; Liang Feng; Guijun Qin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-28       Impact factor: 5.555

Review 10.  miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.

Authors:  Hua Bai; Suhui Wu
Journal:  Onco Targets Ther       Date:  2019-12-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.